TickerGuard
Buy Day today: Neutral (63) Broad market participation · major macro event coming up
RCUS

Arcus Biosciences Inc

Healthcare · Biotechnology

19.30$ +2.1% vs. previous close Closing price · As of: Nov 4, 2026

Statements

Cash Flow

Arcus Biosciences Inc (RCUS) by the numbers: income statement, balance sheet and cash flow, by year or by quarter. In the most recent period (2025), "Operating Cash Flow" came in at -482 million USD. Tick rows to compare them in a chart.

All figures in millions of USD.

Tick rows to compare them in a chart (up to 4)

Cash Flow RCUS
Line item 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
-13 -25 -43 -73 111 -256 438 -306 -170 -482
1.3 2.6 3.7 3.6 3.0 4.0 6.0 8.0 10 10
0.1 0.5 3.9 9.0 22 55 65 73 76 60
0.1 0.8 3.4 10 22 55 76 – – –
3.6 25 1.3 0.1 208 -376 623 -71 22 -194
4.1 5.5 3.7 1.9 3.1 26 6.0 24 6.0 2.0
-39 -49 -113 59 -434 -3.9 -413 194 -84 66
– – – – – 5.0 – – – –
70 108 125 -0.1 -0.1 0.0 0.0 – – –
– – – – – – 0.0 0.0 47 49
70 107 129 1.1 439 237 33 33 277 488
18 33 -27 -13 115 -26 58 -79 23 72
-17 -31 -47 -75 108 -282 432 -330 -176 -484

Data as of: November 4, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?